Purpose: The purpose of this study was to evaluate whether affected bowel in Crohn's disease patients can be identified by observing decreased peristalsis (frozen bowel sign) using cine balanced steady-state free precession (cine BSSFP) images. Materials and methods: 5 radiologists independently reviewed cine BSSFP sequences from randomized MR Enterography (MRE) exams for 30 normal and 30 Crohn's disease patients, graded overall small bowel peristalsis from slowest to fastest, and graded peristalsis for the most abnormal small bowel segment. Sensitivity and specificity of the frozen bowel sign for diagnosing Crohn's disease were calculated. T tests of the peristalsis difference between abnormal segments and overall small bowel were conducted. Results: For 5 readers, the sensitivity and specificity of cine BSSFP of the frozen bowel sign for diagnosing Crohn's disease ranged from 70% to 100% and 87% to 100%, respectively. There were significant differences in peristalsis between abnormal small bowel segments and the overall small bowel for Crohn's patients, but not in the overall small bowel between normal-MRE patients and Crohn's disease patients. Conclusion: Abnormal Crohn's small bowel segments have significantly decreased peristalsis compared to normal small bowel, which can be identified using cine BSSFP sequences as the frozen bowel sign.
well-known imaging features are evaluated using a combination of unenhanced and post-contrast T1-weighted images, usually with fat suppression, T2-weighted images with and without fat suppression, and more recently diffusion-weighted images [16] [17] [18] [19] . However, there are times when these sequences are not completely diagnostic for inflammatory bowel disease, and having additional imaging criteria would be useful.
Small bowel peristalsis evaluation is another method to determine if the small bowel is inflamed, thus making functional evaluation an additional imaging parameter. First established with fluoroscopy, small bowel peristalsis can be evaluated with MRE using a cine balanced steady-state free precession series (cine BSSFP) [20] . In patients with known Crohn's disease, inflamed small bowel segments can have motility changes which usually manifest as decreased or absent peristalsis compared to normal small bowel segments [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] .
The utility of small bowel peristalsis evaluation as an additional parameter to diagnose inflamed small bowel segments is well established in prior publications when there is a known diagnosis of Crohn's disease [27] [28] [29] [30] [31] . However, many times in clinical practice the diagnosis of Crohn's disease is not known, and MRE is performed to determine if inflammatory bowel disease is present. In this case, having a sequence which can be used to detect inflamed bowel segments without a priori knowledge of underlying inflammatory bowel disease is valuable.
Thus, the purpose of our study was to determine if abnormal small bowel segments in Crohn's disease patients can be identified by observing decreased peristalsis using the cine BSSFP series alone, without knowing if a patient has inflammatory bowel disease and without referring to other pulse sequences. We also introduce an imaging sign which describes this decreased peristalsis called the ''frozen bowel sign.''
Materials and methods

Patients
Institutional Review Board approval was obtained for this retrospective study prior to evaluating archived imaging studies and examining the electronic medical records. MRE exams were collected from our institution's PACS between January 1, 2008 and December 23, 2011 using the following search criteria: ''MR Enterography,'' ''Small Bowel Enterography,'' ''MRE,'' ''VoLumen,'' ''Enterography,'' and ''Crohn's Disease.'' This search yielded a total of 655 cases from which MRE exams were randomly selected for 60 patients (23 male, 37 female; age range 15-76 years; mean age 41.8 years) including 30 normal and 30 abnormal exams. All selected exams included a cine series obtained without prior administration of any antiperistaltic agent. All 30 patients with abnormal exams had a clinical diagnosis of Crohn's disease and active and/or chronic Crohn's disease diagnosed on MRE. Of these 30 patients, 12 had active bowel inflammation, 12 had active with chronic bowel inflammation, and 6 had chronic bowel inflammation on MRE. The 30 patients with normal MRE exams (''normal-MRE patients'') had a variety of indications such as weight loss, abdominal pain, mesenteric ischemia, appendiceal polyp, duplication cyst, and GI bleed, but no documented Crohn's disease or inflammatory bowel disease on either the clinical history or MRE. Exclusion criteria included (1) MRE report stating the examination was limited by motion artifact; (2) any MRE performed without intravenous contrast; and (3) if a 0.1% weight per volume barium sulfate suspension (VoLumen; Bracco Diagnostics, Princeton, NJ) was not administered or it was unclear if this was administered based on the radiology report and/or documentation by the MR technologist.
Reference standard
Of the 30 patients with abnormal MRE exams, Crohn's disease was confirmed with histopathology specimens in 26 patients obtained by endoscopic biopsy in 22 patients and surgical resection in 4 patients. The 4 remaining patients with a clinical diagnosis of Crohn's disease had prior endoscopic biopsies confirming inflammation. Concordant pathology results within 6 months of the MRE exam were available for 13 patients and within 12 months for 16 patients.
MR enterography
MRE examinations were performed on 1.5 T MR Systems (Philips Intera, Philips Medical Systems, Best, Netherlands; Philips Achieva, Philips Medical Systems, Best, Netherlands; Siemens Espree, Siemens Medical Solutions, Erlangen, Germany; or General Electric Signa HDxt, GE Medical Systems, Milwaukee, Wisconsin). Multichannel phase array coils were used for each case including a SENSE body coil (Philips Intera), SENSE XL torso coil (Philips Achieva), 8-channel body coil (GE Signa HDxt) or 2 contiguous torso coils (Siemens Espree). Patients were required to fast for 2-4 h before the exam. One bottle (450 ml each) of VoLumen was administered orally every 20 min, beginning 1 h before the exam. When possible, patients were scanned in the prone position (N = 51/60 patients were scanned prone; N = 5/9 of patients scanned supine were Crohn's disease patients). For all cases, pre-gadolinium coronal and axial single-shot heavily T2-weighted images (TE~200) and post-gadolinium axial fat suppressed moderately T2-weighted images (TE~80) were obtained. Pre-and post-gadolinium 3D gradient echo (3D GRE) images were obtained using 0.1 mmol/kg of gadobenate dimeglumine (MultiHance, Milano, Italy) at a rate of 2 mL/s using a power injector (Spectris Solaris; Medrad, Warrendale, PA). Pre-gadolinium and two coronal dynamic post-gadolinium (3D GRE) series followed by a coronal delayed (3D GRE) series approximately 5 min later were obtained. Delayed post-gadolinium axial (3D GRE) images were also obtained. Finally, a coronal cine repetitive balanced steady-state free precession series was obtained with free breathing. For cine series, 150-500 images were obtained at 6-20 locations, each containing 25 phases and a series acquisition time of approximately 4 min. The cine temporal resolution was 1-2 s per image and the flip angle ranged from 45°to 70°, depending on the MR system. The specific pulse sequence parameters are listed in Table 1 including ranges from the lowest to the highest.
Image analysis
Cine sequences with examples of 5 progressive grades of peristalsis ranging from 1 to 5 (1 = slowest and 5 = fastest) were created by the study coordinators on a digital PACS workstation (Philips iSite Version 3.5.86, Philips Healthcare, Andover, MA, USA), based on reviewing the cine sequences from study patients and numerous other non-study patients (Fig. 1 ). After this, 5 abdominal imaging attending radiologists with between 5 and 25 years of MRI experience (FG, 12 years; DM, 25 years; PO, 13 years; SD, 5 years; CR, 9 years) were trained by reviewing the cine series that demonstrated the 5 peristalsis grades as well as 4 abnormal MRE exams. None of the 9 training MRE exams were from the study population. Next, the 5 radiologists were asked to review in isolation the cine series from the 30 normal and 30 abnormal study cases, in random order. The readers were blinded to other images and any clinical information. Cine sequences were reviewed on a Philips iSite PACS workstation in a manner that is similar to interpreting the entire MRE study although no other sequences were reviewed. To avoid reader fatigue, there was no restriction on the amount of time required to review each cine sequence and there was no requirement to complete all 60 interpretations at one time. For each case, using only the cine sequence at a default frame rate of 6 frames per second (which was the same rate as the 9 training cases), overall small bowel peristalsis was graded from 1 to 5. Then, the radiologist was asked to analyze the entire small bowel for an abnormal segment, which was defined as a segment with decreased peristalsis relative to the overall small bowel plus abnormal morphology such as wall thickening, fixed narrowing, or abnormal signal intensity. Since the cine pulse sequence is used for evaluating bowel motility, peristalsis was the predominant feature evaluated. If there was one or more small bowel segment with decreased peristalsis, the most abnormal segment was graded from 1 to 5 and then marked by the radiologist to indicate which segment was chosen. Finally, the level of confidence that this bowel segment was abnormal and was recorded using a scale of 1 (lowest) to 5 (highest).
Statistical analysis
Sensitivity and specificity were calculated for the identification of Crohn's by the presence or absence of an abnormal small bowel segment. This binary judgment was expanded by the 5-point confidence rating into a 10-point scale: the highest confidence level + the judgment of an abnormal segment received the highest score; the lowest confidence level + the judgment of an abnormal segment a score just above the midpoint; the lowest confidence level + the judgment of no abnormal segment a score just below the midpoint; and the highest confidence level + the judgment of no abnormal segment received the lowest score. An ROC curve was calculated for this expanded score. Finally, comparisons of the level of motility, as rated on the 5-point scale, were made between the abnormal segment and remainder of the small bowel in Crohn's patients, between the abnormal segment in Crohn's patients and the whole small bowel in normal-MRE patients, and between the remainder of the small bowel in Crohn's patients and the whole small bowel in normal-MRE patients. These comparisons are not symmetrical: the first is analyzed with a paired t test, the latter two with unpaired t tests; and the first and third comparisons have 30 Crohn's and 30 normal patients, while the second has less than 30 Crohn's patients when a reader is inaccurate in identifying Crohn's patients. All statistical analyses were performed with SAS v.9.3 for Windows (SAS Institute, Cary, NC). The Shrout-Fleiss random set intraclass correlation (ICC) [33] was used to measure reliability of the abnormal segment and the overall peristalsis rating. It is interpreted much like Kappa.
Results
The abnormal small bowel segments included the terminal ileum in 20 patients (Figs. 2, 3 , and 4), ileum in 6 patients (Fig. 5) , and neoterminal ileum in 4 patients. The terminal or neoterminal ileum was arbitrarily defined as the last 10 cm of the ileum before the ileocecal junction or an ileocolic anastomosis, respectively [34] . Sensitivity and specificity for diagnosing Crohn's disease by identification of inflamed small bowel segments using the cine BSSFP sequences were calculated for each reader (Table 2) . They were 100%, 100%; 70%, 93%; 97%, 100%; 100%, 100%; and 87%, 97%. The combined ROC curve for all 5 readers is shown in Fig. 6 . The area under the curve is 0.98. Means and standard deviations of overall small bowel peristalsis vs. an abnormal small bowel segment in Crohn's patients were calculated (Table 3 ). Paired t tests of the peristalsis in abnormal small bowel segments in Crohn's patients vs. peristalsis in the remainder of the small bowel was significant for all five readers, with the abnormal small bowel segment lower by 2.0, 1.7, 1.2, 1.9, and 1.5 (t = 9.63-26.91, p < .0001). Means and standard deviations of overall small bowel peristalsis in normal-MRE patients and peristalsis in abnormal small bowel segments in Crohn's patients were calculated (Table 4) . Independent group t tests of the peristalsis in abnormal small bowel segments in Crohn's patients with the overall small bowel peristalsis in normal-MRE patients is also significant for each reader, with the abnormal segment lower by 2.1, 1.9, 1.7, 2.3 and 1.8 (t = 9.54 to 17.38, p < .0001).
Means and standard deviations of overall small bowel peristalsis in normal-MRE patients and Crohn's patients were calculated (Table 5) . The difference between overall small bowel peristalsis for normal-MRE patients vs.
Crohn's disease patients was not statistically significant, except for reader 3 (t = 2.14, p < 0.05). The ICCs calculated for interobserver reliability were .39 for overall small bowel peristalsis and .79 for detecting an abnormal small bowel segment.
Discussion
Our results show that using cine BSSFP sequences with a 5-point quantitative grading system, blinded to a prior history of inflammatory bowel disease and without referring to other sequences, radiologists can differentiate normal from abnormal small bowel segments, allowing Crohn's disease to be diagnosed with high sensitivity and specificity. This includes detection of abnormal small bowel segments compared to the overall small bowel in both Crohn's disease patients and patients without inflammatory bowel disease. However, we found no significant difference in overall small bowel peristalsis between patients with Crohn's disease and those without a history of inflammatory bowel disease. This latter finding differs from Bickelhaupt et al. who prospectively evaluated 13 symptomatic Crohn's disease patients and showed that small bowel peristalsis decreased in both diseased and non-diseased segments in Crohn's disease patients [29] . This discrepancy in overall small bowel peristalsis may be related to patient selection and a relatively lower degree of acuity of bowel inflammation in our patient population which included patients with active and chronic Crohn's disease. To the best of our knowledge, this is the first study that used cine MRE to detect abnormal small bowel peristalsis to diagnose Crohn's disease when interpreting radiologists were blinded to patient history. In the study by Menys et al., the terminal ileum was evaluated in 28 patients, all of which had prior histologically proven Crohn's disease and endoscopic terminal ileal biopsy within 4 weeks of the MRE [28] . Froehlich et al. evaluated MRE studies for 40 patients with biopsy-proven Crohn's disease and clinically active Crohn's disease at the time of the MRE [31] . Girometti et al. prospectively evaluated 52 Crohn's disease patients with clinical evidence of active Crohn's disease onset or relapse [30] . Kitazume et al. evaluated MRE studies for 6 Crohn's disease patients who had longitudinal ulcers in the terminal ileum or ileum that was confirmed by colonoscopy, contrast radiology, or surgery [27] . Finally, Bickelhaupt et al. prospectively evaluated 13 patients with a known diagnosis of Crohn's disease [29] . In all prior similar cine MRE literature, the diagnosis of Crohn's disease was known without comparison to a control group. We chose our methodology to address the relatively common clinical situation of interpreting MRE exams to identify inflammatory bowel disease without a confirmed diagnosis of Crohn's disease. The fact that 5 radiologists could accurately diagnose inflamed small bowel segments without a priori knowledge of the diagnosis of Crohn's disease further supports the diagnostic value of cine BSSFP sequences for this indication.
Many centers use a spasmolytic agent to decrease motion-induced bowel blur in an effort to improve the image quality of 3D gradient echo (3D GRE) series, which can take up to 20 s to acquire. In one European study, 92% of academic radiologists surveyed used a spasmolytic agent, most commonly hyoscine butylbromide (Buscopan Ò , Boehringer-Ingelheim, Ingelheim, Germany) which is an agent approved outside of the USA [12] . In the USA, most centers use glucagon (GlucaGen Ò , Novo Nordisk, DK-2880 Bagsvaerd) [26, 32] . However, it is important to note that cine BSSFP sequences should be performed before spasmolytic agents are administered. Otherwise, these agents will decrease small bowel peristalsis which will likely limit the accuracy of this sequence in characterizing small bowel peristalsis.
Research has also shown that MRE interpretation may be accurate even without using spasmolytic agents [6, 14, 35] , particularly for evaluating patients with known or suspected inflammatory bowel disease. Excluding a spasmolytic agent in an MRE protocol shortens exam time, simplifies the exam protocol, reduces exam costs, and eliminates drug side effects, making the exam more tolerable to patients. In fact, eliminating the use of an antiperistaltic agent may actually help diagnose abnormal small bowel segments, based on the difference in peristalsis, effectively becoming a parameter of tissue contrast. The decreased peristalsis of inflamed small bowel segments can decrease the bowel blur that is inherent in 3D GRE sequences, making the abnormal segments stand out compared to normal small bowel [24, 31] . Thus, inflamed small bowel segments may have decreased peristalsis on cine BSSFP sequences and may also be better defined on 3D GRE sequences (Figs. 2, 3, 4 , and 5). Since abnormal small bowel segments may appear frozen in time on these sequences, this decreased peristalsis can be termed the ''frozen bowel sign.'' In our study, the interobserver reliabilities calculated with the ICC were on the border of poor and fair for evaluating overall small bowel peristalsis (.39), but between very good and excellent for detecting an abnormal small bowel segment (.79). Evaluation of overall small bowel peristalsis is likely more subjective, with five possible peristalsis grades, and might have benefited from further training. However, detecting the presence of an abnormal small bowel segment (''the frozen bowel sign''), which is the more important measure, had more than acceptable reliability.
This study has several limitations. Recent pathologic proof was not available for 14 of the 30 abnormal cases evaluated in the study. However, each of the 30 patients with abnormal MRE exams had an established clinical diagnosis of Crohn's disease and all patients had a biopsy confirming Crohn's and/or bowel inflammation. Also, obtaining pathologic proof confirming bowel inflammation is one of the limitations of MRE research in general. In most cases, pathologic proof in the small bowel is only available for the terminal ileum, which is the small bowel segment most accessible by colonoscopy, or by surgical resection. Cases that have surgical resection will by definition have more advanced disease that does not respond to more conservative treatment, thus skewing results. Another study limitation is that not all patients were scanned in the prone position (85% of patients) which may affect the overall peristalsis rate due to differences in patient positioning, while the cine acquisition was variable at 1-2 s per image. Both of these factors may have decreased the accuracy of overall small bowel peristalsis evaluation between different patients. However, this will likely have little effect when evaluating the peristalsis of an abnormal small bowel segment compared to the overall small bowel for the same patient. Another limitation is that this study is not a prospective study with random assignment, and therefore selection bias is possible at the different stages of the study design. Next, decreased small bowel peristalsis is not specific for Crohn's disease and can be due to a number of conditions including adhesions, motility disorders, or other segmental or diffuse small bowel processes. Finally, we did not evaluate if peristalsis was affected differently in active vs. chronically inflamed small bowel segments or in active bowel inflammation that involves only the small bowel mucosa vs. the bowel wall.
In conclusion, abnormal small bowel segments in Crohn's disease have significantly decreased peristalsis compared to normal small bowel segments in both Crohn's disease patients and patients without a history of inflammatory bowel disease. The cine BSSFP series is excellent for recognizing this decreased peristalsis, making it a valuable addition to the standard MRE protocol.
